Advertisement

Migraine

  • Steven B. Graff-RadfordEmail author
Chapter

Abstract

  • Migraine is typically underdiagnosed and undertreated.

  • There is no cure for migraine; nevertheless there are numerous interventions that may help restore an improve life for sufferers. These measures should consider the patient in as broad an aspect as possible.

  • Triggering factors, neurogenic inflammation, vascular changes, and pain transmission should all be addressed aggressively.

  • Individualizing treatment and use of multiple modalities is essential.

References

  1. 1.
    Vos T, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163–96.Google Scholar
  2. 2.
    Lipton RB, Stewart WF, Diamond S, et al. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41(7):646–57.CrossRefPubMedGoogle Scholar
  3. 3.
    Lipton RB, Scher AI, Kolodner K, et al. Migraine in the United States: epidemiology and patterns of health care use. Neurology. 2002;58(6):885–94.CrossRefPubMedGoogle Scholar
  4. 4.
    Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders. Cephalalgia. 1988;8(Suppl 7):1–96.Google Scholar
  5. 5.
    Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders. Cephalalgia. 2004;24(Suppl 1):160. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013:33:629–808.Google Scholar
  6. 6.
    GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1545–1602.Google Scholar
  7. 7.
    Waters WE. Headache (series in clinical epidemiology). London: Croom Helm; 1986.Google Scholar
  8. 8.
    Selby G, Lance JW. Observations on 500 cases of migraine and allied vascular headache. J Neurol Neurosurg Psychiatry. 1960;47:23–32.CrossRefGoogle Scholar
  9. 9.
    Silberstein SD, Lipton RB, Goadsby PJ. Headache in clinical practice. Oxford: ISIS Medical Media; 1998.Google Scholar
  10. 10.
    Woods RP, Iacoboni M, Maziotta JC. Bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med. 1994;331:1689–92.CrossRefPubMedGoogle Scholar
  11. 11.
    Moskowitz MA, Henrikson BM, Markowitz S, Saito K. Intra- and extravascular nociceptive mechanisms and the pathogenesis of head pain. In: Olsen J, Edvinsson L, editors. Basic mechanisms of headache. Amsterdam: Elsevier; 1988. p. 429.Google Scholar
  12. 12.
    Moskowitz MA, Cutrer FM. Sumatriptan: a receptor-targeted treatment for migraine. Annu Rev Med. 1993;44:145–54.CrossRefPubMedGoogle Scholar
  13. 13.
    Peroutka SJ. The pharmacology of current antimigraine drugs. Headache. 1990;30(Suppl 1):5–11.CrossRefPubMedGoogle Scholar
  14. 14.
    Weiller C, May A, Limmeroth, et al. Brain stem activation in spontaneous human migraine attacks. Nat Med. 1995;1:658–60.CrossRefPubMedGoogle Scholar
  15. 15.
    Strassman AM, Raymond SA, Burstein R. Sensitization of meningeal sensory neurons and the origin of headaches. Nature. 1996;384:560–3.CrossRefPubMedGoogle Scholar
  16. 16.
    Burstein R. Deconstructing migraine headache into peripheral and central sensitization. Pain. 2000;89:107–10.CrossRefGoogle Scholar
  17. 17.
    Burstein R, Yarnitsky D, Goor-Aryeh I, et al. An association between migraine and cutaneous allodynia. Ann Neurol. 2000;47:614–24.CrossRefPubMedGoogle Scholar
  18. 18.
    Burstein R, Jukubowski M, Burstein R. Analgesic Triptan action in animal model of intracranial pain: a race against the development of central sensitization. Ann Neurol. 2004;55:27–36.CrossRefPubMedGoogle Scholar
  19. 19.
    Lipton RB, Dodick D, Sadosvsky R, Kolodner K, Endicott J, Hettiarachchi J, Harrison W. A self-administered screener for migraine in primary care: the ID MigraineTM validation study. Neurology. 2003;61:375–82.CrossRefPubMedGoogle Scholar
  20. 20.
    Silberstein SD. Preventive treatment of migraine: an overview. Cephalalgia. 1997;17(2):67–72.CrossRefPubMedGoogle Scholar
  21. 21.
    Silberstein SD, Saper JR, Freitag FG. Migraine diagnosis and treatment. In: Silberstein SD, Lipton RB, Dalessio DE, editors. Wolff’s headache and other head pain. 7th ed. Oxford: Oxford University Press; 2001. p. 121–237.Google Scholar
  22. 22.
    Silberstein SD, Goadsby PJ. Migraine: preventive treatment. Cephalalgia. 2002;22(7):491–512.CrossRefPubMedGoogle Scholar
  23. 23.
    Diener HC, Kaube H, Limmroth V. A practical guide to the management and prevention of migraine. Drugs. 1998;56(5):811–24.CrossRefPubMedGoogle Scholar
  24. 24.
    Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000a;55(6):754–62.CrossRefPubMedGoogle Scholar
  25. 25.
    Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB, Diener H-C, Brin MF. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache J Head Face Pain. 2010;50(6):921–36.CrossRefGoogle Scholar
  26. 26.
    Gray RN, Goslin RE, McCrory DC, et al. Drug treatments for the prevention of migraine headache. technical review 2.3. Duke University: US Dept of Health and Human Services, Agency for Health Care Policy and Research; February 1999. NTIS Accession No. PB99–127953. Available at: http://www.clinpol.mc.duke.edu/.
  27. 27.
    Ramadan NM, Silberstein SD, Freitag FG, Gilbert TT, Frishberg BM. Evidence-based guidelines for migraine headache in prevention of migraine. Neurology [serial online]. Available at: http://www.neurology.org. Accessed 25 Apr 2000.
  28. 28.
    Snow V, Weiss K, Wall E, et al. Pharmacologic management of acute attacks of migraine and prevention of migraine headache. Ann Intern Med. 2002;137:840–9.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.The Pain Center, UCLA School of DentistryLos AngelesUSA

Personalised recommendations